DRG Market Assessment reports
Access comprehensive market intelligence covering Disease Landscape & Forecast, Epidemiology Intelligence, Biosimilars Intelligence, China In-depth and more.
Report
June 24, 2022
Insomnia – Access & Reimbursement – Access & Reimbursement – Digital Therapeutics in Mental Health (US)
The rapid growth of digital therapeutic (DTx) solutions to treat medical problems, fueled by increased demand for telehealth services amid the COVID-19 pandemic, has tasked U.S. payers and pharmacy…
Report
June 15, 2022
Opioid Addiction – Current Treatment – Current Treatment: Physician Insights – Opioid Addiction (US)
Opioid addiction is a chronic disease, generally driven by a strong and irresistible urge or craving for the intake of opioid drugs and an inability to stop despite negative consequences to health…
Report
March 15, 2022
Attention-Deficit-Hyperactivity Disorder – Epidemiology – Extrapolated Worldwide Coverage
Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key attention-deficit/hyperactivity disorder (ADHD) patient populations…
